Critical structural and functional roles for the N-terminal insertion sequence in surfactant protein B analogs

PLoS ONE

Volumn 5, Issue 1, 2010, Pages

  Walther, Frans J ^a,b   Waring, Alan J ^a,c   Hernandez Juviel, Jose M ^a   Gordon, Larry M ^a   Wang, Zhengdong ^d   Jung, Chun Ling ^c   Ruchala, Piotr ^c   Clark, Andrew P ^e   Smith, Wesley M ^e   Sharma, Shantanu ^e   Notter, Robert H ^d,f  

^a UCLA MEDICAL CENTER   (United States)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^e CALIFORNIA STATE POLYTECHNIC UNIVERSITY   (United States)

^f UNIVERSITY OF ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SURFACTANT PROTEIN B;

ALGORITHM; ALPHA HELIX; AMINO TERMINAL SEQUENCE; ARTICLE; BETA SHEET; GEL ELECTROPHORESIS; MOLECULAR DOCKING; MOLECULAR DYNAMICS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ANALYSIS; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN STRUCTURE; SIMULATION; STRUCTURE ANALYSIS; SURFACE PLASMON RESONANCE; SURFACE TENSION;

AMINO ACID SEQUENCE; ANIMALS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; MALE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; PROTEIN CONFORMATION; PULMONARY SURFACTANT-ASSOCIATED PROTEIN B; RATS; RATS, SPRAGUE-DAWLEY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SURFACE PLASMON RESONANCE;

EID: 77952526093     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008672     Document Type: Article

References (117)

1. Goerke J (1998) Pulmonary surfactant: functions and molecular composition. Biochim Biophys Acta 1408: 79-89.
2. Perez-Gil J (2002) Molecular interactions in pulmonary surfactant films. Biol Neonate 81: 6-15.
3. Possmayer F (1988) A proposed nomenclature for pulmonary surfactantassociated proteins. Am Rev Respir Dis 138: 990-998.
4. Walther FJ, Gordon LM, Zasadzinski JA, Sherman MA, Waring AJ (2000) Surfactant protein B and C analogues. Mol Genet Metab 71: 342-351.
5. Walther FJ, Waring AJ, Sherman MA, Zasadzinski JA, Gordon LM (2007) Hydrophobic surfactant proteins and their analogues. Neonatology 91: 303-310.
6. Nogee LM, Garnier G, Dietz HC, Singer L, Murphy AM, et al. (1994) A mutation in the surfactant protein B gene responsible for fatal neonatal respiratory disease in multiple kindreds. J Clin Invest 93: 1860-1863.
7. Bridges JP, Xu Y, Na C-L, Wong HR, Weaver TE (2006) Adaptation and increased susceptibility to infection associated with constitutive expression of misfolded SP-C. J Cell Biol 172: 395-407.
8. Notter RH (2000) Lung surfactants: Basic science and clinical applications. New York: Marcel Dekker. 444 p.
9. Chess P, Finkelstein JN, Holm BA, Notter RH (2005) Surfactant replacement therapy in lung injury. In: Notter RH, Finkelstein JN, Holm BA, eds. Lung injury: Mechanisms, pathophysiology, and therapy. Boca Raton: Taylor Francis Group, Inc. pp 617-663.
10. Willson DF, Chess PR, Wang Z, Notter RH (2005) Pulmonary surfactant: biology and therapy. In: Wheeler WH, Shanley TA, eds. Pediatric Critical Care Medicine: Basic Science and Clinical Evidence. London: Springer-Verlag. pp 453-466.
11. Curstedt T, Johansson J (2006) New synthetic surfactant - how and when? Biol Neonate 89: 336-339.
12. Chang Y, Wang Z, Notter RH, Wang Z, Qu L, et al. (2004) Synthesis and interfacial behavior of sulfur-containing analogs of lung surfactant dipalmitoyl phosphatidylcholine. Bioorgan Med Chem Lett 14: 5983-5986.
13. Chang Y, Wang Z, Schwan AL, Wang Z, Holm BA, et al. (2005) Surface properties of sulfur- and ether-linked phophonolipids with and without purified hydrophobic lung surfactant proteins. Chem Phys Lipids 137: 77-93.
14. Notter RH, Schwan AL, Wang Z, Waring AJ (2007) Novel phospholipaseresistant lipid/peptide synthetic lung surfactants. Mini Rev Med Chem 7: 932-944.
15. Walther FJ, Hernandez-Juviel J, Gordon LM, Waring AJ, Stenger P, et al. (2005) Comparison of three lipid formulations for synthetic surfactant with a surfactant protein B analog. Exp Lung Res 31: 563-579.
16. Walther FJ, Waring AJ, Hernandez-Juviel J, Gordon LM, Schwan AL, et al. (2007) Dynamic surface activity of a fully synthetic phospholipase-resistant lipid/peptide lung surfactant. PLoS ONE 2: e1039.
17. Johansson J, Curstedt T, Jornvall H (1991) Surfactant Protein B: Disulfide bridges, structural properties, and kringle similarities. Biochemistry 30: 6917-6921.
18. Bruhn H (2005) A short guided tour through functional and structural features of saposin-like proteins. Biochem J 389: 249-257.
19. Ahn VE, Faull KF, Whitelegge JP, Fluharty AL, Prive GG (2003) Crystal structure of saposin B reveals a dimeric shell for lipid binding. Proc Natl Acad Sci USA 100: 38-43.
20. Hawkins CA, de Alba E, Tjandra N (2005) Solution structure of human saposin C in a detergent environment. J Mol Biol 346: 1381-1392.
21. Munford RS, Sheppard PO, O'Hara PJ (1995) Saposin-like proteins (SAPLIP) carry out diverse functions on a common backbone structure. J Lipid Res 36: 1653-1663.
22. Hawgood S (2004) Surfactant Protein B: Structure and function. Biol Neonate. pp 285-289.
23. Andersson M, Curstedt T, Jornvall H, Johansson J (1995) An amphipathic helical motif common to tumourolytic polypeptide NK-lysin and pulmonary surfactant polypeptide SP-B. FEBS Lett 362: 328-332.
24. Power JH, Doyle IR, Davidson K, Nicholas TE (1999) Ultrastructural and protein analysis of surfactant in the Australian lungfish Neoceratodus forsteri: evidence for conservation of composition for 300 million years. J Exp Biol 202: 2543-2550.
25. Vandenbussche G, Clercx A, Clercx M, Curstedt T, Johansson J, et al. (1992) Secondary structure and orientation of the surfactant protein SP-B in a lipid environment: A Fourier transform infrared spectroscopy study. Biochemistry 31: 9169-9176.
26. Pastrana-Rios B, Taneva S, Keough KM, Mautone AJ, Mendelsohn R (1995) External reflection absorption infrared spectroscopy study of lung surfactant proteins SP-B and SP-C in phospholipid monolayers at the air/water interface. Biophys J 69: 2531-2540.
27. Cruz A, Casals C, Perez-Gil J (1995) Conformational flexibility of pulmonary surfactant proteins SP-B and SP-C, studied in aqueous organic solvents. Biochim Biophys Acta 1255: 68-76.
28. Zaltash S, Palmblad M, Curstedt T, Johansson J, Persson B (2000) Pulmonary surfactant protein B: a structural model and a functional analogue. Biochim Biophys Acta 1466: 179-186.
29. Serrano AG, Perez-Gil J (2006) Protein-lipid interactions and surface activity in the pulmonary surfactant system. Chem Phys Lipids 141: 105-118.
30. Gordon LM, Horvath S, Longo ML, Zasadzinski JA, Taeusch W, et al. (1996) Conformation and molecular topography of the N-terminal segment of surfactant protein B in structure-promoting environments. Protein Sci 5: 1662-1675.
31. Longo ML, Bisagno AM, Zasadzinski JA, Bruni R, Waring AJ (1993) A function of lung surfactant protein SP-B. Science 261: 453-456.
32. Lipp MM, Lee KYC, Zasadzinski JA, Waring AJ (1996) Phase and morphology changes in lipid monolayers induced by SP-B protein and its amino-terminal peptide. Science 273: 1196-1199.
33. Lipp MM, Lee KYC, Takamoto DY, Zasadzinski JAN, Waring AJ (1998) Coexistence of buckled and flat monolayers. Physical Rev Lett 81: 1650-1653.
34. Waring AJ, Taeusch HW, Bruni R, Amirkhanian JD, Fan BR, et al. (1989) Synthetic amphipathic sequences of Surfactant Protein-B mimic several physicochemical and in vivo properties of native pulmonary surfactant proteins. Peptide Res 2: 308-313.
35. Walther FJ, Hernandez-Juviel J, Bruni R, Waring AJ (1998) Protein composition of synthetic surfactant affects gas exchange in surfactant-deficient rats. Pediatr Res 43: 666-673.
36. 1-25 in neonatal and acute respiratory distress syndrome. Exp Lung Res 28: 623-640.
37. Walther FJ, Hernandez-Juviel J, Mercado PE, Gordon LM, Waring AJ (2002) Surfactant with SP-B and SP-C analogues improves lung function in surfactantdeficient rats. Biol Neonate 82: 181-187.
38. Ryan MA, Qi X, Serrano AG, Ikegami M, Perez-Gil J, et al. (2005) Mapping and analysis of the lytic and fusogenic domains of surfactant protein B. Biochemistry 44: 861-872.
39. Bruni R, Taeusch HW, Waring AJ (1991) Surfactant protein B: Lipid interactions of synthetic peptides representing the amino-terminal amphipathic domains. Proc Natl Acad Sci USA 88: 7451-7455.
40. 13C-enhanced Fourier transform infrared spectroscopy. J Peptide Res 55: 330-347.
41. Kurutz JW, Lee KYC (2002) NMR structure of lung surfactant peptide SPB( 11-25). Biochemistry 41: 9627-9636.
42. Seurynck SL, Patch JA, Barron AE (2005) Simple, helical peptoid analogs of lung surfactant protein B. Chem Biol 12: 77-88.
43. Kang JH, Lee MK, Kim KL, Hahm K-S (1996) The relationship between biophysical activity and the secondary structure of synthetic peptides from the pulmonary surfactant protein SP-B. Biochem Mol Biol Int 40: 617-627.
44. Booth V, Waring AJ, Walther FJ, Keough KMW (2004) NMR structures of the C-terminal segment of surfactant protein B in detergent micelles and hexafluoro-2-propanol. Biochemistry 43: 15187-15194.
45. Revak SD, Merritt TA, Hallman M, Heldt GP, La Polla RJ, et al. (1991) The use of synthetic peptides in the formation of biophysically and biologically active pulmonary surfactants. Pediatr Res 29: 460-465.
46. Cochrane CG, Revak SD (1991) Pulmonary surfactant B (SP-B): Structurefunction relationships. Science 254: 566-568.
47. Baatz JE, Sarin V, Absolom DR, Baxter C, Whitsett JA (1991) Effects of surfactant-associated protein SP-B synthetic analogs on the structure and surface activity of model membrane bilayers. Chem Phys Lipids 60: 163-178.
48. Waring AJ, Walther FJ, Gordon LM, Hernandez-Juviel JM, Hong T, et al. (2005) The role of charged amphipathic helices in the structure and function of surfactant protein B. J Peptide Res 66: 364-374.
49. Sarker M, Waring AJ, Walther FJ, Keough KMW, Booth V (2007) Structure of Mini-B, a functional fragment of surfactant protein B, in detergent micelles. Biochemistry 46: 11047-11056.
50. Perez-Gil J, Keough KMW (1991) Identical and similar amino acid sequences in the pulmonary surfactant proteins SP-B and SP-C and hemerythrin and myohemerythrin - an example of "biochemical Velcro"? Biochem Int 25: 715-721.
51. Lee KY, Majewski J, Kuhl TL, Howes PB, Kjaer K, et al. (2001) Synchrotron X-ray study of lung surfactant-specific protein SP-B in lipid monolayers. Biophys J 81: 572-585.
52. Serrano AG, Ryan M, Weaver TE, Perez-Gil J (2006) Critical structurefunction determinants within the N-terminal region of pulmonary surfactant protein SP-B. Biophys J 90: 238-249.
53. Seurynck-Servoss SL, Dohm MT, Barron AE (2006) Effects of including an Nterminal insertion region and arginine-mimetic side chains in helical peptoid analogues of lung surfactant protein B. Biochemistry 45: 11809-11818.
54. Fields CG, Lloyd DH, Macdonald RL, Ottenson KM, Noble RL (1991) HBTU activation for automated Fmoc solid-phase peptide synthesis. Pept Res 4: 95-101.
55. Waring AJ, Faull KF, Leung C, Chang-Chien A, Mercado P, et al. (1996) Synthesis, secondary structure and folding of the bend region of lung surfactant protein B. Pept Res 9: 28-39.
56. Fan BR, Nguyen T, Waring AJ, Taeusch HW (1990) Staining properties of bovine low molecular weight hydrophobic surfactant proteins after polyacrylamide gel electrophoresis. Anal Biochem 186: 41-45.
57. Fan BR, Bruni R, Taeusch HW, Findlay R, Waring AJ (1991) Antibodies against synthetic amphipathic helical sequences of surfactant protein SP-B detect a conformational change in the native protein. FEBS Lett 282: 220-224.
58. Stenger PC, Alonso C, Zasadzinski JA, Waring AJ, Jung C-L, et al. (2009) Environmental tobacco smoke effects on lung surfactant film organization. Biochim Biophys Acta 1788: 358-370.
59. Gordon LM, Nisthal A, Lee AB, Eskandari S, Ruchala P, et al. (2008) Structural and functional properties of peptides based on the N-terminus of HIV-1 gp41 and the C-terminus of the amyloid-beta protein. Biochim Biophys Acta 1778: 2127-2137.
60. Cairo CW, Strzelec A, Murphy RM, Kiessling LL (2002) Affinity-based inhibition of beta-amyloid toxicity. Biochemistry 41: 8620-8629.
61. Trovato A, Chiti F, Maritan A, Seno F (2006) Insight into the structure of amyloid fibrils from the analysis of globular proteins. PloS Comput Biol 2: e170.
62. Trovato A, Seno F, Tosatto SCE (2007) The PASTA server for protein aggregation prediction. Protein Eng Des Sel 20: 521-523.
63. de Groot NS, Pallares I, Aviles FX, Vendrell J, Ventura S (2005) Prediction of "hot spots" of aggregation in disease-linked polypeptides. BMC Struct Biol 5: 18.
64. Conchillo-Sole O, de Groot NS, Aviles FX, Vendrell J, Daura X, et al. (2007) AGGRESCAN: a server for the prediction and evaluation of "hot spots" of aggregation in polypeptides. BMC Bioinformatics 8: 65.
65. Castillo V, Ventura S (2009) Amyloidogenic regions and interaction surfaces overlap in globular proteins related to conformational diseases. PLoS Comput Biol 5: e1000476.
66. Kim W, Hecht MH (2005) Sequence determinants of enhanced amyloidogenicity of Alzheimer ABeta42 peptide relative to Abeta40. J Biol Chem 280: 35069-35076.
67. de Groot NS, Aviles FX, Vendrell J, Ventura S (2006) Mutagenesis of the central hydrophobic cluster in ABeta42 Alzheimer's peptide. Side-chain properties correlate with aggregation propensities. FEBS J 273: 658-668.
68. Ivanova MI, Sawaya MR, Gingery M, Eisenberg D (2004) An amyloid-forming segment of beta2-microglobulin suggests a molecular model for the fibril. Proc Natl Acad Sci USA 101: 10584-10589.
69. Surewicz WK, Mantsch HH (1988) New insight into protein secondary structure from resolution-enhanced infrared spectra. Biochim Biophys Acta 952: 115-130.
70. Lindahl E, Hess B, van der Spoel D (2001) GROMACS 3.0: a package for molecular simulation and trajectory analysis. J Mol Model 7: 306-317.
71. Roccatano D, Fioroni M, Zacharias M, Colombo G (2005) Effect of hexafluoroisopropanol alcohol on the structure of melittin: A molecular dynamics simulation study. Protein Sci 14: 2582-2589.
72. Kabsch W, Sander C (1983) Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 22: 2577-2637.
73. Chen R, Li L, Weng Z (2003) ZDOCK: an initial-stage protein-docking algorithm. Proteins 52: 80-87.
74. Biswas N, Waring AJ, Walther FJ, Dluhy RA (2007) Structure and conformation of the disulfide bond in dimeric lung surfactant peptides SPB1-25 and SP-B8-25. Biochim Biophys Acta 1768: 1070-1082.
75. Gray JJ, Moughon SE, Kortemme T, Schueler-Furman O, Misura KM, et al. (2003) Protein-protein docking predictions for the CAPRI experiment. Proteins 52: 118-122.
76. Yount NY, Kupferwasser D, Spisni A, Dutz SM, Ramjan ZH, et al. (2009) Selective reciprocity in antimicrobial activity versus cytotoxicity of hBD-2 and crotamine. Proc Natl Acad Sci U S A 106: 14972-14977.
77. Bourbigot S, Dodd E, Horwood C, Cumby N, Fardy L, et al. (2009) Antimicrobial peptide RP-1 structure and interactions with anionic versus zwitterionic micelles. Biopolymers 91: 1-13.
78. Sammalkorpi M, Karttunen M, Haataja M (2007) Structural properties of ionic detergent aggregates: a large-scale molecular dynamics study of sodium dodecyl sulfate. J Phys Chem B 111: 11722-11733.
79. Schurch S, Bachofen H, Goerke J, Possmayer F (1989) A captive bubble method reproduces the in situ behavior of lung surfactant monolayers. J Appl Physiol 67: 2389-2396.
80. Schurch S, Bachofen H, Goerke J, Green F (1992) Surface properties of rat pulmonary surfactant studied with the captive bubble method: absorption, hysteresis, stability. Biochim Biophys Acta 1103: 127-136.
81. Schurch S, Bachofen H, Possmayer F (2001) Surface activity in situ, in vivo, and in the captive bubble surfactometer. Comp Biochem Physiol A 129: 195-207.
82. Schoel WM, Schurch S, Goerke J (1994) The captive bubble method for the evaluation of pulmonary surfactant: surface tension, area, and volume calculations. Biochim Biophys Acta 1200: 281-290.
83. Malcolm JD, Elliot CD (1980) Interfacial tension from height and diameter of a single profile drop or captive bubble. Can J Chem Eng 58: 151-153.
84. Byler DM, Susi H (1986) Examination of the secondary structure of protein by deconvolved FTIR spectra. Biopolymers 25: 469-487.
85. Hong D-P, Hoshino M, Kuboi R, Goto Y (1999) Clustering of fluorinesubstituted alcohols as a factor responsible for their marked effect on proteins and peptides. J Amer Chem Soc 121: 8427-8433.
86. Fioroni M, Burger K, Mark AE, Roccatano D (2001) Model of 1,1,1,3,3,3-hexafluoro-propan-2-ol for molecular dynamics simulations. J Phys Chem B 105: 10967-10975.
87. Gast K, Siemer A, Zirwer D, Damaschun G (2001) Fluoroalcohol-induced structural changes of proteins: some aspects of cosolvent-protein interactions. Eur Biophys J 30: 273-283.
88. Gerig JT (2004) Structure and solvation of melittin in 1,1,1,3,3,3,-hexafluoro-2-propanol/water. Biophys J 86: 3166-3175.
89. Imamura T (2006) Protein-Surfactant Interactions. In: Somasundaran P, ed. Encyclopedia of Surface and Colloid Science. New York: Taylor & Francis. pp 5251-5263.
90. Reynolds JA, Tanford C (1970) Binding of dodecyl sulfate to proteins at high binding ratios. Possible implications for the state of proteins in biological membranes. Proc Natl Acad Sci U S A 66: 1002-1007.
91. Tanford C (1980) The hydrophobic effect: Formation of micelles and biological membranes. New York: Wiley. 233 p.
92. Zaltash S, Griffiths WJ, Beck D, Duan C-X, Weaver TE, et al. (2001) Membrane activity of (Cys48Ser) lung surfactant protein B increases with dimerisation. Biol Chem 382: 933-939.
93. Audie J (2009) Development and validation of an empirical free energy function for calculating protein-protein binding free energy surfaces. Biophys Chem 139: 84-91.
94. Gustafsson M, Thyberg J, Naslund J, Eliasson E, Johansson J (1999) Amyloid fibril formation by pulmonary surfactant protein C. FEBS Lett 464: 138-142.
95. Dluhy RA, Shanmukh S, Leapard JB, Kruger P, Baatz JE (2003) Deacylated pulmonary surfactant protein SP-C transforms from alpha-helical to amyloid fibril structure via a pH -dependent mechanism: an infrared structural investigation. Biophys J 85: 2417-2429.
96. Johansson J, Nilsson G, Stromberg R, Robertson B, Jornvall H, et al. (1995) Secondary structure and biophysical activity of synthetic analogues of the pulmonary surfactant polypeptide SP-C. Biochem J 307: 535-541.
97. 1-25) in phospholipid bilayers. Biochemistry 42: 4015-4027.
98. Aguilar M-I, Small DH (2005) Surface plasmon resonance for the analysis of beta-amyloid interactions and fibril formation in Alzheimer's disease research. Neurotoxicity Res 7: 17-27.
99. Chen R, Weng Z (2002) Docking unbound proteins using shape complementarity, desolvation, and electrostatics. Proteins 47: 281-294.
100. Lyskov S, Gray JJ (2008) The RosettaDock server for local protein-protein docking. Nucleic Acids Res 36: W233-W238.
101. Kaznessis YN, Kim S, Larson RG (2002) Specific mode of interaction between components of model pulmonary surfactants using computer simulations. J Mol Biol 322: 569-582.
102. Freites JA, Choi Y, Tobias DJ (2003) Molecular dynamics simulations of a pulmonary surfactant protein B peptide in a lipid monolayer. Biophys J 84: 2169-2180.
103. 1-25 with DPPC monolayers: Insights into interactions and peptide position and orientation. Biophys J 88: 1577-1592.
104. Lee H, Kandasamy SK, Larson RG (2005) Molecular dynamics simulations of the anchoring and tilting of the lung-surfactant peptide SP-B1-25 in palmitic acid monolayers. Biophys J 89: 3807-3821.
105. Lund S, Orlowski S, de Foresta B, Champeil P, le Maire M, et al. (1989) Detergent structure and associated lipid as determinants in the stabilization of solubilized Ca2+-ATPase from sarcoplasmic reticulum. J Biol Chem 264: 4907-4915.
106. Li S-C, Goto NK, Williams KA, Deber CM (1996) Alpha-helical, but not betasheet, propensity of proline is determined by peptide environment. Proc Natl Acad Sci USA 93: 6676-6681.
107. Kahn MC, Anderson GJ, Anyan WR, Hall SB (1995) Phosphatidylcholine molecular species of calf lung surfactant. Am J Physiol 269: L567-L573.
108. Cockshutt AM, Possmayer F (1992) Metabolism of surfactant lipids and protein in the developing lung. In: Robertson B, van Golde LMG, Batenburg JJ, eds. Pulmonary Surfactant: From Molecular Biology to Clinical Practice. Amsterdam: Elsevier. pp 339-378.
109. Small DM (1986) The Physical Chemistry of Lipids: From Alkanes to Phospholipids. New York: Plenum Press. 672 p.
110. Mingarro I, Lukovic D, Vilar M, Perez-Gil J (2008) Synthetic pulmonary surfactant preparations: new developments and future trends. Curr Med Chem 15: 393-403.
111. Johansson J, Curstedt T, Robertson B (1994) The proteins of the surfactant system. Eur Respir J 7: 372-391.
112. Creuwels LA, van Golde LMG, Haagsman HP (1997) The pulmonary surfactant system: biochemical and clinical aspects. Lung 175: 1-39.
113. McDonnell PA, Opella SJ (2009) Effect of detergent concentration on multidimensional solution NMR spectra of membrane proteins in micelles. J Magn Reson 102: 120-125.
114. Alattia JR, Shaw JE, Yip CM, Prive GG (2006) Direct visualization of saposin remodelling of lipid bilayers. J Mol Biol 362: 943-953.
115. Beck DC, Ikegami M, Na C-L, Zaltash S, Johansson J, et al. (2000) The role of homodimers in surfactant protein B function in vivo. J Biol Chem 275: 3365-3370.
116. Lee KYC, Lipp MM, Zasadzinski JA, Waring AJ (1997) Effects of lung surfactant specific protein SP-B and model SP-B peptide on lipid monolayers at the air-water interface. Colloids Surfaces A: Physicochem Eng Aspects 128: 225-242.
117. Wimley WC, White SH (1996) Experimentally determined hydrophobicity scale for proteins at membrane interfaces. Nat Struct Biol 3: 842-848.